The Inflammatory Cascade in Acute Pancreatitis: Relevance to Clinical Disease

Surgical Clinics of North America

Volumn 87, Issue 6, 2007, Pages 1325-1340

  Elfar, Mohammed ^a   Gaber, Lillian W ^b   Sabek, Omaima ^a   Fischer, Craig P ^a   Gaber, A Osama ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; APROTININ; ENZYME PRECURSOR; GABEXATE MESILATE; LEXIPAFANT; NAFAMSTAT MESILATE; OCTREOTIDE; PANCREAS ENZYME; PROTEINASE; PROTEINASE INHIBITOR; SOMATOSTATIN; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; ULINASTATIN; VASCULAR CELL ADHESION MOLECULE 1;

ABDOMINAL PAIN; ACUTE PANCREATITIS; ALCOHOL CONSUMPTION; BACTERIAL TRANSLOCATION; CELL INFILTRATION; CLINICAL FEATURE; DISEASE COURSE; DISEASE PREDISPOSITION; DRUG TARGETING; ENDOTOXEMIA; ENZYME ACTIVATION; ENZYME RELEASE; EXOCRINE SECRETION; GENE MUTATION; GRANULOCYTE; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; INCIDENCE; INFLAMMATION; INFLAMMATORY CELL; LABORATORY TEST; MACROPHAGE; MORBIDITY; MORTALITY; NONHUMAN; PANCREAS; PATHOGENESIS; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ACUTE DISEASE; ALCOHOL DRINKING; ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GALLSTONES; HUMANS; INFLAMMATION; PANCREAS; PANCREATITIS; PROTEASE INHIBITORS;

EID: 36349001745     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2007.09.002     Document Type: Review

References (109)

1. Yadav D., and Lowenfels A.B. Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review. Pancreas 33 4 (2006) 323-330
2. Frey C.F., Zhou H., Harvey D.J., et al. The incidence and case-fatality rates of acute biliary, alcoholic, and idiopathic pancreatitis in California, 1994-2001. Pancreas 33 4 (2006) 336-344
3. Lindkvist B., Appelros S., Manjer J., et al. Trends in incidence of acute pancreatitis in a Swedish population: is there really an increase?. Clin Gastroenterol Hepatol 2 9 (2004) 831-837
4. Gloor B., Muller C.A., Worni M., et al. Late mortality in patients with severe acute pancreatitis. Br J Surg 88 7 (2001) 975-979
5. Mutinga M., Rosenbluth A., Tenner S.M., et al. Does mortality occur early or late in acute pancreatitis?. Int J Pancreatol 28 2 (2000) 91-95
6. Buechler M.H., Hauke A., and Malfertheiner P. Follow-up after acute pancreatitis-morphology and function. In: Beger H., and Buechler M. (Eds). Acute pancreatitis-research and clinical management (1987), Springer-Verlag, Berlin 367
7. Scuro A., Angelini G., and Cavallini G. Late outcome of acute pancreatitis. In: Gyr K., Singer M.V., and Sarles H. (Eds). Pancreatitis: concepts and classifications. Proceedings of the Second International Symposium on Classification of Pancreatitis in Marseille, France, March 28-30 (1984), Excerpta Medica 403
8. Sherwood M.W., Prior I.A., Voronina S.G., et al. Activation of trypsinogen in large endocytic vacuoles of pancreatic acinar cells. Proc Natl Acad Sci U S A 104 13 (2007) 5674-5679
9. Lerch M.M., and Gorelick F.S. Early trypsinogen activation in acute pancreatitis. Med Clin North Am 84 3 (2000) 549-563 viii
10. Hirota M., Ohmuraya M., and Baba H. The role of trypsin, trypsin inhibitor, and trypsin receptor in the onset and aggravation of pancreatitis. J Gastroenterol 41 9 (2006) 832-836
11. Szmola R., Kukor Z., and Sahin-Toth M. Human mesotrypsin is a unique digestive protease specialized for the degradation of trypsin inhibitors. J Biol Chem 278 49 (2003) 48580-48589
12. Vege S, Chari ST. Pathogenesis of acute pancreatitis. Uptodate Online; (2007). Available at: http://www.utdol.com/utd/content/topic.do?topicKey=pancdis/4682&selectedTitle=5∼114&source=search_result.
13. Bialek R., Willemer S., Arnold R., et al. Evidence of intracellular activation of serine proteases in acute cerulein-induced pancreatitis in rats. Scand J Gastroenterol 26 2 (1991) 190-196
14. Rinderknecht H. Activation of pancreatic zymogens. Normal activation, premature intrapancreatic activation, protective mechanisms against inappropriate activation. Dig Dis Sci 31 3 (1986) 314-321
15. Scheele G., Adler G., and Kern H. Exocytosis occurs at the lateral plasma membrane of the pancreatic acinar cell during supramaximal secretagogue stimulation. Gastroenterology 92 2 (1987) 345-353
16. Wedgwood K.R., Adler G., Kern H., et al. Effects of oral agents on pancreatic duct permeability. A model of acute alcoholic pancreatitis. Dig Dis Sci 31 10 (1986) 1081-1088
17. Harvey M.H., Wedgwood K.R., Austin J.A., et al. Pancreatic duct pressure, duct permeability, and acute pancreatitis. Br J Surg 76 8 (1989) 859-862
18. Sanfey H., Bulkley G.B., and Cameron J.L. The pathogenesis of acute pancreatitis. The source and role of oxygen-derived free radicals in three different experimental models. Ann Surg 201 5 (1985) 633-639
19. Raraty M.G., Murphy J.A., McLoughlin E., et al. Mechanisms of acinar cell injury in acute pancreatitis. Scand J Surg 94 2 (2005) 89-96
20. Steer M.L. Pathogenesis of acute pancreatitis. Digestion 58 Suppl 1 (1997) 46-49
21. Halangk W., Lerch M.M., Brandt-Nedelev B., et al. Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J Clin Invest 106 6 (2000) 773-781
22. Lundberg A.H., Eubanks III J.W., Henry J., et al. Trypsin stimulates production of cytokines from peritoneal macrophages in vitro and in vivo. Pancreas 21 1 (2000) 41-51
23. Ramudo L., Manso M.A., Sevillano S., et al. Kinetic study of TNF-alpha production and its regulatory mechanisms in acinar cells during acute pancreatitis induced by bile-pancreatic duct obstruction. J Pathol 206 1 (2005) 9-16
24. Sugimoto Y., Hayakawa T., Kondo T., et al. Peritoneal absorption of pancreatic enzymes in bile-induced acute pancreatitis in dogs. J Gastroenterol Hepatol 5 5 (1990) 493-498
25. Lankisch P.G., Buschmann-Kaspari H., Otto J., et al. Correlation of pancreatic enzyme levels with the patient's recovery from acute edematous pancreatitis. Klin Wochenschr 68 11 (1990) 565-569
26. Wilson C., and Imrie C.W. Effective intraperitoneal antiprotease therapy for taurocholate-induced pancreatitis in rats. Br J Surg 77 11 (1990) 1252-1255
27. Leese T., Holliday M., Watkins M., et al. A multicentre controlled clinical trial of high-volume fresh- frozen plasma therapy in prognostically severe acute pancreatitis. Ann R Coll Surg Engl 73 4 (1991) 207-214
28. Guice K.S., Oldham K.T., Remick D.G., et al. Anti-tumor necrosis factor antibody augments edema formation in caerulein-induced actue pancreatitis. J Surg Res 51 6 (1991) 495-499
29. Norman J.G., Franz M.G., Fink G.S., et al. Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Ann Surg 221 6 (1995) 625-631 [discussion: 631-4]
30. Norman J., Franz M., Messina J., et al. Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 117 6 (1995) 648-655
31. Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg 175 1 (1998) 76-83
32. Moreau J.A., Zinsmeister A.R., Melton III L.J., et al. Gallstone pancreatitis and the effect of cholecystectomy: a population-based cohort study. Mayo Clin Proc 63 5 (1988) 466-473
33. Bess M.A., Edis A.J., and van Heerden J.A. Hyperparathyroidism and pancreatitis. Chance or a causal association?. JAMA 243 3 (1980) 246-247
34. Purohit V., Russo D., Salin M., et al. Mechanisms of alcoholic pancreatitis: introduction and summary of a symposium. Pancreas 27 4 (2003) 281-355
35. Schmidt J., and Klar E. [Etiology and pathophysiology of acute pancreatitis]. Ther Umsch 53 5 (1996) 322-332 [in German]
36. Bachem M.G., Zhou Z., Zhou S., et al. Role of stellate cells in pancreatic fibrogenesis associated with acute and chronic pancreatitis. J Gastroenterol Hepatol 21 Suppl 3 (2006) S92-S96
37. Cosen-Binker L.I., and Gaisano H.Y. Recent insights into the cellular mechanisms of acute pancreatitis. Can J Gastroenterol 21 1 (2007) 19-24
38. Lam P.P., Cosen Binker L.I., Lugea A., et al. Alcohol redirects CCK-mediated apical exocytosis to the acinar basolateral membrane in alcoholic pancreatitis. Traffic 8 5 (2007) 605-617
39. Lerch M.M., Saluja A.K., Runzi M., et al. Pancreatic duct obstruction triggers acute necrotizing pancreatitis in the opossum. Gastroenterology 104 3 (1993) 853-861
40. Diehl A.K., Holleman Jr. D.R., Chapman J.B., et al. Gallstone size and risk of pancreatitis. Arch Intern Med 157 15 (1997) 1674-1678
41. Garg P.K., Tandon R.K., and Madan K. Is biliary microlithiasis a significant cause of idiopathic recurrent acute pancreatitis? A long-term follow-up study. Clin Gastroenterol Hepatol 5 1 (2007) 75-79
42. Ros E., Navarro S., Bru C., et al. Occult microlithiasis in idiopathic acute pancreatitis: prevention of relapses by cholecystectomy or ursodeoxycholic acid therapy. Gastroenterology 101 6 (1991) 1701-1709
43. Lightner A.M., and Kirkwood K.S. Pathophysiology of gallstone pancreatitis. Front Biosci 6 (2001) E66-E76
44. Ramudo L., De Dios I., Yubero S., et al. ICAM-1 and CD11b/CD18 expression during acute pancreatitis induced by bile-pancreatic duct obstruction: effect of N-acetylcysteine. Exp Biol Med (Maywood) 232 6 (2007) 737-743
45. Toskes P.P. Hyperlipidemic pancreatitis. Gastroenterol Clin North Am 19 4 (1990) 783-791
46. Dominguez-Munoz J.E., Junemann F., and Malfertheiner P. Hyperlipidemia in acute pancreatitis. Cause or epiphenomenon?. Int J Pancreatol 18 2 (1995) 101-106
47. Dominguez-Munoz J.E., Malfertheiner P., Ditschuneit H.H., et al. Hyperlipidemia in acute pancreatitis. Relationship with etiology, onset, and severity of the disease. Int J Pancreatol 10 3-4 (1991) 261-267
48. Gan S.I., Edwards A.L., Symonds C.J., et al. Hypertriglyceridemia-induced pancreatitis: a case-based review. World J Gastroenterol 12 44 (2006) 7197-7202
49. Fortson M.R., Freedman S.N., and Webster III P.D. Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol 90 12 (1995) 2134-2139
50. Mithofer K., Fernandez-del Castillo C., Frick T.W., et al. Acute hypercalcemia causes acute pancreatitis and ectopic trypsinogen activation in the rat. Gastroenterology 109 1 (1995) 239-246
51. Ward J.B., Petersen O.H., Jenkins S.A., et al. Is an elevated concentration of acinar cytosolic free ionised calcium the trigger for acute pancreatitis?. Lancet 346 8981 (1995) 1016-1019
52. Mallory A., and Kern Jr. F. Drug-induced pancreatitis: a critical review. Gastroenterology 78 4 (1980) 813-820
53. Cuthbertson C.M., and Christophi C. Disturbances of the microcirculation in acute pancreatitis. Br J Surg 93 5 (2006) 518-530
54. Cohn J.A., Friedman K.J., Noone P.G., et al. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 339 10 (1998) 653-658
55. Le Bodic L., Bignon J.D., Raguenes O., et al. The hereditary pancreatitis gene maps to long arm of chromosome 7. Hum Mol Genet 5 4 (1996) 549-554
56. Gorry M.C., Gabbaizedeh D., Furey W., et al. Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis. Gastroenterology 113 4 (1997) 1063-1068
57. Whitcomb D.C., Gorry M.C., Preston R.A., et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 14 2 (1996) 141-145
58. Whitcomb D.C., Preston R.A., Aston C.E., et al. A gene for hereditary pancreatitis maps to chromosome 7q35. Gastroenterology 110 6 (1996) 1975-1980
59. Pfutzer R.H., Barmada M.M., Brunskill A.P., et al. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 119 3 (2000) 615-623
60. Sharer N., Schwarz M., Malone G., et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 339 10 (1998) 645-652
61. Choudari C.P., Yu A.C., Imperiale T.F., et al. Significance of heterozygous cystic fibrosis gene (cystic fibrosis transmembrane conductance regulator mutations) in idiopathic pancreatitis. Gastroenterology 114 10 (1998) A447
62. Rattner D.W. Experimental models of acute pancreatitis and their relevance to human disease. Scand J Gastroenterol Suppl 219 (1996) 6-9
63. Granger J., and Remick D. Acute pancreatitis: models, markers, and mediators. Shock 24 Suppl 1 (2005) 45-51
64. Norman J.G., Fink G.W., Messina J., et al. Timing of tumor necrosis factor antagonism is critical in determining outcome in murine lethal acute pancreatitis. Surgery 120 3 (1996) 515-521
65. Rinderknecht H. Genetic determinants of mortality in acute necrotizing pancreatitis. Int J Pancreatol 16 1 (1994) 11-15
66. Balakrishnan V.S., Guo D., Rao M., et al. Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin. Kidney Int 65 4 (2004) 1449-1460
67. Jaber B.L., Rao M., Guo D., et al. Cytokine gene promoter polymorphisms and mortality in acute renal failure. Cytokine 25 5 (2004) 212-219
68. Grady T., Saluja A., Kaiser A., et al. Edema and intrapancreatic trypsinogen activation precede glutathione depletion during caerulein pancreatitis. Am J Physiol 271 1 Pt 1 (1996) G20-G26
69. O'Keefe S.J., Lee R.B., Li J., et al. Trypsin secretion and turnover in patients with acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 289 2 (2005) G181-G187
70. Saluja A.K., Donovan E.A., Yamanaka K., et al. Cerulein-induced in vitro activation of trypsinogen in rat pancreatic acini is mediated by cathepsin B. Gastroenterology 113 1 (1997) 304-310
71. Prinz R.A. Mechanisms of acute pancreatitis. Vascular etiology. Int J Pancreatol 9 (1991) 31-38
72. Klar E., Messmer K., Warshaw A.L., et al. Pancreatic ischaemia in experimental acute pancreatitis: mechanism, significance, and therapy. Br J Surg 77 11 (1990) 1205-1210
73. Reilly P.M., Toung T.J., Miyachi M., et al. Hemodynamics of pancreatic ischemia in cardiogenic shock in pigs. Gastroenterology 113 3 (1997) 938-945
74. Rinderknecht H. Fatal pancreatitis, a consequence of excessive leukocyte stimulation?. Int J Pancreatol 3 2-3 (1988) 105-112
75. Kingsnorth A. Role of cytokines and their inhibitors in acute pancreatitis. Gut 40 1 (1997) 1-4
76. Bhatia M., Saluja A.K., Singh V.P., et al. Complement factor C5a exerts an anti-inflammatory effect in acute pancreatitis and associated lung injury. Am J Physiol Gastrointest Liver Physiol 280 5 (2001) G974-G978
77. Grewal H.P., Kotb M., el Din A.M., et al. Induction of tumor necrosis factor in severe acute pancreatitis and its subsequent reduction after hepatic passage. Surgery 115 2 (1994) 213-221
78. Hughes C.B., Gaber L.W., Kotb M., et al. Induction of acute pancreatitis in germ-free rats: evidence of a primary role for tumor necrosis factor-alpha. Surgery 117 2 (1995) 201-205
79. Hughes C.B., Henry J., Kotb M., et al. Up-regulation of TNF alpha mRNA in the rat spleen following induction of acute pancreatitis. J Surg Res 59 6 (1995) 687-693
80. Agarwal N., and Pitchumoni C.S. Acute pancreatitis: a multisystem disease. Gastroenterologist 1 2 (1993) 115-128
81. Tenner S., Fernandez-del Castillo C., Warshaw A., et al. Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis. Int J Pancreatol 21 2 (1997) 105-110
82. Folch E., Salas A., Panes J., et al. Role of P-selectin and ICAM-1 in pancreatitis-induced lung inflammation in rats: significance of oxidative stress. Ann Surg 230 6 (1999) 792-798 [discussion: 798-9]
83. Hartwig W., Jimenez R.E., Fernandez-del Castillo C., et al. Expression of the adhesion molecules Mac-1 and L-selectin on neutrophils in acute pancreatitis is protease- and complement-dependent. Ann Surg 233 3 (2001) 371-378
84. Cobo J.C., Abraham E., Bland R.D., et al. Sequential hemodynamic and oxygen transport abnormalities in patients with acute pancreatitis. Surgery 95 3 (1984) 324-330
85. Schmid S.W., Uhl W., Friess H., et al. The role of infection in acute pancreatitis. Gut 45 2 (1999) 311-316
86. Andersson R., and Wang X.D. Gut barrier dysfunction in experimental acute pancreatitis. Ann Acad Med Singapore 28 1 (1999) 141-146
87. Kazantsev G.B., Hecht D.W., Rao R., et al. Plasmid labeling confirms bacterial translocation in pancreatitis. Am J Surg 167 1 (1994) 201-206 [discussion 206-7]
88. Eubanks III J.W., Sabek O., Kotb M., et al. Acute pancreatitis induces cytokine production in endotoxin-resistant mice. Ann Surg 227 6 (1998) 904-911
89. Kingsnorth A.N., Galloway S.W., and Formela L.J. Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis. Br J Surg 82 10 (1995) 1414-1420
90. Johnson C.D., Kingsnorth A.N., Imrie C.W., et al. Double blind, randomised, placebo-controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. Gut 48 1 (2001) 62-69
91. Andriulli A., Leandro G., Clemente R., et al. Meta-analysis of somatostatin, octreotide and gabexate mesilate in the therapy of acute pancreatitis. Aliment Pharmacol Ther 12 3 (1998) 237-245
92. Messori A., Rampazzo R., Scroccaro G., et al. Effectiveness of gabexate mesilate in acute pancreatitis. A meta-analysis. Dig Dis Sci 40 4 (1995) 734-738
93. Grewal H.P., Mohey el Din A., Gaber L., et al. Amelioration of the physiologic and biochemical changes of acute pancreatitis using an anti-TNF α polyclonal antibody. Am J Surg 167 1 (1994) 214-218 [discussion: 218-9]
94. Hughes C.B., Gaber L.W., Mohey el-Din A.B., et al. Inhibition of TNF α improves survival in an experimental model of acute pancreatitis. Am Surg 62 1 (1996) 8-13
95. Hughes C.B., Grewal H.P., Gaber L.W., et al. Anti-TNF α therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat. Am J Surg 171 2 (1996) 274-280
96. Malleo G., Mazzon E., Genovese T., et al. Effects of thalidomide in a mouse model of cerulein-induced acute pancreatitis. Shock (2007) [epub ahead of print]
97. Brivet F.G., Emilie D., and Galanaud P. Pro- and anti-inflammatory cytokines during acute severe pancreatitis: an early and sustained response, although unpredictable of death. Parisian Study Group on Acute Pancreatitis. Crit Care Med 27 4 (1999) 749-755
98. Denham W., Denham D., Yang J., et al. Transient human gene therapy: a novel cytokine regulatory strategy for experimental pancreatitis. Ann Surg 227 6 (1998) 812-820
99. Norman J., Yang J., Fink G., et al. Severity and mortality of experimental pancreatitis are dependent on interleukin-1 converting enzyme (ICE). J Interferon Cytokine Res 17 2 (1997) 113-118
100. Paszkowski A.S., Rau B., Mayer J.M., et al. Therapeutic application of caspase 1/interleukin-1beta-converting enzyme inhibitor decreases the death rate in severe acute experimental pancreatitis. Ann Surg 235 1 (2002) 68-76
101. Jaworek J., Bonior J., Pierzchalski P., et al. Leptin protects the pancreas from damage induced by caerulein overstimulation by modulating cytokine production. Pancreatology 2 2 (2002) 89-99
102. Callicutt C.S., Sabek O., Fukatsu K., et al. Diminished lung injury with vascular adhesion molecule-1 blockade in choline-deficient ethionine diet-induced pancreatitis. Surgery 133 2 (2003) 186-196
103. Lundberg A.H., Fukatsu K., Gaber L., et al. Blocking pulmonary ICAM-1 expression ameliorates lung injury in established diet-induced pancreatitis. Ann Surg 233 2 (2001) 213-220
104. Lundberg A.H., Granger D.N., Russell J., et al. Quantitative measurement of P- and E-selectin adhesion molecules in acute pancreatitis: correlation with distant organ injury. Ann Surg 231 2 (2000) 213-222
105. Hughes C.B., el-Din A.B., Kotb M., et al. Calcium channel blockade inhibits release of TNF α and improves survival in a rat model of acute pancreatitis. Pancreas 13 1 (1996) 22-28
106. Vonlaufen A., Aurrand-Lions M., Pastor C.M., et al. The role of junctional adhesion molecule C (JAM-C) in acute pancreatitis. J Pathol 209 4 (2006) 540-548
107. Bhatia M., Sidhapuriwala J.N., Sparatore A., et al. Treatment with H2s-releasing diclofenac protects mice against acute pancreatitis-associated lung injury. Shock (2007) [epub ahead of print]
108. Gultekin F.A., Kerem M., Tatlicioglu E., et al. Leptin treatment ameliorates acute lung injury in rats with cerulein-induced acute pancreatitis. World J Gastroenterol 13 21 (2007) 2932-2938
109. Yasuda T., Takeyama Y., Ueda T., et al. Protective effect of caspase inhibitor on intestinal integrity in experimental severe acute pancreatitis. J Surg Res 138 2 (2007) 300-307